15.–17. Okt. 2025
Rome
Europe/Berlin Zeitzone

Development of a DNA origami nanosensing platform for diagnostic analysis of ADAMTS-13 proteolytic activity

Nicht eingeplant
15m
Rome

Rome

Palazzetto Mattei

Sprecher

Gereon Brüggenthies

Beschreibung

Current advances in DNA nanotechnology have enabled the design and synthesis of complex and functional nanostructures, including artificial DNA motors, DNA crystals, and DNA nanopores [1]. A notable development is a DNA origami-based biosensor in which the biorecognition and signal transduction elements are completely decoupled [2]. This makes it a valuable tool for detecting single molecules of nucleic acids, single-nucleotide polymorphisms, as well as various protein targets. Proteases are an important class of biomolecules that require improved strategies for activity detection.
In this work, we focus on a clinically relevant protease, A Disintegrin And Metalloprotease with ThromboSpondin repeats 13 (ADAMTS-13), which plays a key role in coagulation disorders [3]. We present a DNA origami-based biosensor capable of directly reporting ADAMTS-13 activity in blood samples. This approach enables rapid, near-patient analysis, offering a simple, cost-effective, and easy-to-use point-of-care testing (POCT) solution. Such a tool could significantly aid clinical decision-making in emergency settings by facilitating timely differentiation between coagulation-related conditions.
References
[1] Pengfei Zhan et al. 2023. Recent Advances in DNA Origami-Engineered Nanomaterials and Applications. Chemical Reviews. 123:3976-4050
[2] Lennart Grabenhorst et al. 2025. Engineering modular and tunable single-molecule sensors by decoupling sensing from signal output. Nat. Nanotechnol. 20, 303–310
[3] HM Tsai. 1996 Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood. 87 (10): 4235–4244

Autoren

Gereon Brüggenthies Jasmin Arnold (Institute of Clinical Chemistry and Pathobiology, Klinikum rechts der Isar of the Technische Universität München (MRI-TUM))

Co-Autoren

Prof. Philip Tinnefeld (Department of Chemistry and Center for NanoScience, Ludwig-Maximilians-Universtität München) Dr. Susanne Weber (Institute of Clinical Chemistry and Pathobiology, Klinikum rechts der Isar of the Technische Universität München (MRI-TUM)) Dr. Viktorija Glembockyte (Max Planck Institute for Medical Research (MPImF))

Präsentationsmaterialien